НовостиBenzingaTruist Securities Maintains Buy on Carlsmed, Raises Price Target to $23 Truist Securities Maintains Buy on Carlsmed, Raises Price Target to $23 Benzinga 2026.11.11 13:03 (GMT+0) Открыть на Benzinga Другие новости